Please join us for a live webinar on the 16th June 15.00–16.00 at which Professor Axel Behrens (Cancer Research UK Convergence Science Centre Scientific Director) is pleased to host Dr Alex Ivanov and Prof Luca Magnani.
About the speakers:
Dr Alex Ivanov
Dr Alex Ivanov is a Lecturer at the Department of Chemistry and co-director of the Network for Sensor Technologies at Imperial College London. His research focuses on the innovation of nanoscale sensors and physical platforms for single-molecule detection that enable the study of fundamental molecules in biology and medicine. Examples include: i) Novel quantum tunnelling single-molecule probes for nucleic acid and protein analysis: Tang et al. Sci. Adv. (2022) 8, eabm8149; Tang et al. Nat. Commun. 12, 3515 (2021); ii) Nanotweezers for single-molecule single-cell biopsy and single-molecule nanotweezers for genetic, gene expression analysis and organelles manipulation in single living cells: Nadappuram et al. Nat. Nanotechnol. (2019) 14(1); Freedman et al. Nat. Commun. (2016) 7, 10217, Zhang et al. Nat. Commun. (2019) 10 (1), 1; iii) Multiplexed Sensing for biomarker fingerprinting directly from liquid biopsies: Ren et al., Adv. Matter. 33 (38), (2021); Cai et al. Nat. Commun. 12, 3515 (2021); Cai, et al. Nat Commun 10 (1), 1797 (2019). Sze, Nat. Commun. 8, 1552, (2017). Ren, Nat. Commun. 8, 586, (2017), to name a few.
Prof Luca Magnani
Professor Magnani is the Chair in Cancer Adaptation and Evolution at Imperial College London. He trained at Purdue University and Dartmouth College before joining Imperial. His laboratory investigates the biology driving hormone dependent breast cancers from early transformation to drug resistant relapse. He is deeply interested in nongenetic mechanisms and the connection between developmental and cancer processes.
To receive information about how to access this event please email firstname.lastname@example.org
Please note: This webinar is exclusively available only to colleagues across the Institute of Cancer Research, Imperial College London, the Royal Marsden Hospital and Imperial College Healthcare.